The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2022

Filed:

Dec. 22, 2017
Applicant:

Duke University, Durham, NC (US);

Inventors:

Tuan Vo-Dinh, Chapel Hill, NC (US);

Brant A. Inman, Durham, NC (US);

Paolo Maccarini, Durham, NC (US);

Greg Palmer, Durham, NC (US);

Yang Liu, Durham, NC (US);

Douglas Weitzel, Durham, NC (US);

Assignee:

Duke University, Durham, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 41/00 (2020.01); A61N 5/00 (2006.01); A61N 5/06 (2006.01); B22F 1/00 (2006.01); C07K 16/28 (2006.01); A61K 33/242 (2019.01); A61K 47/69 (2017.01); A61P 35/02 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); A61B 18/14 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 33/24 (2019.01); A61K 39/395 (2006.01); A61N 1/40 (2006.01); A61N 5/02 (2006.01); A61K 39/00 (2006.01); A61N 5/067 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0052 (2013.01); A61B 18/14 (2013.01); A61B 18/1815 (2013.01); A61B 18/20 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/51 (2013.01); A61K 33/24 (2013.01); A61K 33/242 (2019.01); A61K 39/39558 (2013.01); A61K 47/6929 (2017.08); A61N 1/403 (2013.01); A61N 5/00 (2013.01); A61N 5/025 (2013.01); A61N 5/062 (2013.01); A61N 5/0625 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 35/04 (2018.01); B22F 1/0022 (2013.01); C07K 16/2827 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/1807 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/572 (2013.01); A61N 5/067 (2021.08); A61N 2005/0659 (2013.01); A61N 2005/0661 (2013.01); A61N 2005/0662 (2013.01); B22F 2999/00 (2013.01);
Abstract

The presently disclosed subject matter is directed to a method of treating cancer, such as (but not limited to) metastatic bladder and breast cancer. The disclosed method comprises using two treatment modalities to synergistically treat primary and secondary tumor cells in a subject. The first element of the method comprises administering a therapeutically effective amount of a plasmonics-active metal nanoparticle to a subject comprising a primary cancer and a distant metastatic site, wherein the nanoparticle concentrates at the primary cancer. The method further comprises exposing the subject to photon radiation at the site of the primary cancer. The second element of the disclosed method comprises administering a therapeutically effective amount of an immune checkpoint modulator to the subject. The synergistic combination provides a rapid, safe, and effective treatment of local and distant lesions, better than each modality alone.


Find Patent Forward Citations

Loading…